Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
09/2012
09/27/2012US20120245081 Fas peptide mimetics and uses thereof
09/27/2012US20120244192 Sustained release formulations of peptidomimetic drugs and uses thereof
09/27/2012US20120244188 Treatment of Sensory Disturbance Disorders
09/27/2012US20120244177 Pharmaceutical composition for treatment of dry eye syndrome
09/27/2012US20120244147 Combination therapy of cancer with anti-endoglin antibodies and anti-vegf agents
09/27/2012US20120244077 Methods and compositions for maintenance of a functional wound
09/26/2012EP2502916A1 Organic dicarboxylic acids, salts and preparation method thereof
09/26/2012EP2501802A2 Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells
09/26/2012EP2501409A2 Epithelial membrane protein-2 (emp2) and proliferative vitreoretinopathy (pvr)
09/26/2012EP2501388A1 Use of prostaglandins f2alpha and analogues for the healing of corneal and conjunctival lesions
09/26/2012EP2501372A2 Intravenous infusion of curcumin and a calcium channel blocker
09/26/2012EP2501227A1 Treatment of ophthalmic conditions with fluorenone derivatives
09/26/2012CN1798576B Drug for preventing or treating angiogenic eye diseases
09/26/2012CN1738618B Pharmaceutical compositions and uses thereof
09/26/2012CN1662663B DNA enzyme to inhibit plasminogen activator inhibitor-1
09/26/2012CN102695954A Method for screening drug efficacious in treating dry eye and/or keratoconjunctival disorders and pharmaceutical composition obtained thereby
09/26/2012CN102695505A Isothiozoles for treating conditions of the eye
09/26/2012CN102695498A Compositions & methods for lowering intraocular pressure
09/26/2012CN102690346A Polypeptide treating diabetes, its preparation method and application
09/26/2012CN102690278A Novel pyrimidine-fused cyclic compounds as cytokine inhibitors
09/26/2012CN102690221A 改性的拟赖氨酸化合物 Proposed modification of lysine compound
09/26/2012CN102688479A Composition for preventing xerophthalmia, eye mask with composition and preparation method of eye mask
09/26/2012CN102688364A Medicament for treating tinnitus
09/26/2012CN102688301A Traditional Chinese medicine lotion for treating acute conjunctivitis and preparation method thereof
09/26/2012CN102688227A Borneol-containing salvianolic acid A composition ophthalmic preparation and preparation method thereof
09/26/2012CN102068577B Traditional Chinese medicine (TCM) composition and application thereof
09/26/2012CN101652135B Application of genistein
09/25/2012US8273895 NK1 antagonists
09/25/2012US8273756 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
09/25/2012US8273740 antiallergen; not direct way to change nature of immunological response to allergen; G-protein-coupled "chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)" antagonist for prostaglandin PGD2, that mediates PGD2-dependent migration of blood Th2 cells; ; asthma, rhinitis, COPD
09/25/2012US8273381 Compositions for and methods of controlling olfactory responses to odorants
09/25/2012US8273362 Cationic ophthalmic oil-in-water type emulsion; colloid particles, oily core surrounded by interfacial film; poloxamers, tyloxapol non ionic surfactant; prostaglandin is latanoprost, unoprostone isopropyl; chitosan, chlorhexidine, benzalkonium halide, vegetable oils; eye drops, ointment, ophthalmic gel
09/25/2012US8273358 Activatable clostridial toxins
09/25/2012US8273356 Anti-IgE vaccines
09/25/2012CA2554679C Prophylactic or therapeutic agent for diabetic maculopathy
09/25/2012CA2489427C Combination of azelastine and steroids
09/20/2012WO2012124696A1 Guanidine compound
09/20/2012WO2012124311A1 Novel phenylpyridine derivative and drug containing same
09/20/2012WO2012123515A1 An ophthalmic composition
09/20/2012WO2012122859A1 Human keratinocyte growth factor-1 disulfide variant, preparation method thereof, and application thereof
09/20/2012WO2012103186A3 Androgen composition for treating an opthalmic condition
09/20/2012US20120240245 Methods and compositions for detecting and treating retinal diseases
09/20/2012US20120238938 Method and apparatus for the delivery of photo-chemical (cross-linking) treatment to corneal tissue
09/20/2012US20120238634 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators
09/20/2012US20120238632 Modulators of retinol-retinol binding protein (rbp)-transthyretin (ttr) complex formation
09/20/2012US20120238628 Dihydronaphthalene and naphthalene derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
09/20/2012US20120238593 Heterocyclic compounds and uses thereof
09/20/2012US20120238586 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238577 Prostaglandin transporter inhibitors and uses thereof
09/20/2012US20120238576 Triazine Derivatives and their Therapeutical Applications
09/20/2012US20120238572 Use of substituted quinazoline compounds in treating angiogenesis-related diseases
09/20/2012US20120238558 Kinase inhibitors
09/20/2012US20120238549 Nuclear Hormone Receptor Modulators
09/20/2012US20120238545 Tricyclic pyrazol amine derivatives
09/20/2012US20120238544 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
09/20/2012US20120238536 Method for Treating Retinal Conditions Using an Intraocular Tamponade
09/20/2012US20120238530 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238524 Water-soluble polysaccharide ethers and their use
09/20/2012US20120238519 Ophthalmic composition containing alginic acid or salt thereof
09/20/2012US20120237590 Curcumin combination with anti-type 2 diabetic drugs for prevention and treatment of disease sequelae, drug-related adverse reactions, and improved glycemic control
09/20/2012US20120237565 Pegylated polyplexes containing two or more different polymers for polynucleotide delivery
09/20/2012US20120237552 Peptoid Agonists of Nerve Growth Factor and Their Use as Medicaments
09/20/2012US20120237542 Multivalent pneumococcal polysaccharide-protein conjugate composition
09/20/2012US20120237528 Human Tissue Factor Antibody and Uses Thereof
09/20/2012US20120237514 Vascular endothelial cell growth factor antagonists and uses thereof
09/20/2012US20120237504 Compositions and methods for treating inflammation and fibrosis
09/20/2012US20120237497 Compositions and methods for producing clostridial collagenases
09/20/2012US20120237485 Trabecular Meshwork Stem Cells
09/20/2012US20120237474 Fluorinated diaryl urea derivatives
09/20/2012US20120237473 Compositions And Methods For Cell Based Retinal Therapies
09/20/2012DE102011015142A1 Agens zur Prophylaxe und Behandlung altersassoziierter Krankheiten und Störungen sowie zur Verlängerung der Lebensdauer Agent for the prophylaxis and treatment of age-related diseases and disorders, as well as extending the life
09/20/2012CA2830407A1 Methods of diagnosing and treating vascular associated maculopathy and symptoms thereof
09/20/2012CA2830157A1 Guanidine compound
09/20/2012CA2830043A1 Novel phenylpyridine derivative and drug containing same
09/20/2012CA2829164A1 An ophthalmic composition
09/19/2012EP2500018A1 Preventing and/or Treating Cardiovascular Disease and/or Associated Heart Failure
09/19/2012EP2499144A1 Quinoline and quinoxaline derivatives as kinase inhibitors
09/19/2012EP2499126A1 Fused bicyclic pyridine and pyrazine derivatives as kinase inhibitors
09/19/2012EP2498768A1 Pharmaceutical combination of prostaglandin compound and nsaid for the treatment of glaucoma and ocular hypertension
09/19/2012CN102686578A Bicyclic heteroaryl inhibitors of PDE4
09/19/2012CN102686577A Compounds as tyrosine kinase modulators
09/19/2012CN102675449A Deletion form human keratinocyte growth factor-I disulfide bond mutation form and use thereof
09/19/2012CN102675206A Preparation method of novel acetylcholinesterase inhibitor, and activity thereof
09/19/2012CN102671184A Application of marine fish polypeptide in preparing eye drops for relieving asthenopia
09/19/2012CN102671061A Traditional Chinese medicine for treating chronic suppurative otitis media, as well as application and preparation method of same
09/19/2012CN102671052A Chinese medicinal composition for treating Meniere's syndrome
09/19/2012CN102671043A Traditional Chinese medicine for treating children chronic otitis media with effusion, as well as preparation method and application thereof
09/19/2012CN102671031A Traditional Chinese medicine for treating senile vitreous opacitees
09/19/2012CN102671030A Chinese medicinal preparation for curing auricular perichondritis
09/19/2012CN102671021A Chinese medicament for treating chronic catarrhal otitis media and preparation method
09/19/2012CN102670993A Chinese medicament for treating cataract
09/19/2012CN102670861A Traditional Chinese medicine preparation for treating infantile acute suppurative otitis media
09/19/2012CN102670853A Traditional Chinese medicine ear lotion for preventing and curing tinnitus
09/19/2012CN102670851A Selenium-enriched Chinese medicinal herb eye refreshing drops
09/19/2012CN102670836A Traditional Chinese medicine for curing diabetic retinopathy
09/19/2012CN102670760A Traditional Chinese medicine eye drops for treating trachoma
09/19/2012CN102670748A Chinese medicine for treating acute glaucom
09/19/2012CN102670721A Traditional Chinese medicine preparation for curing secretory otitis media and preparation method thereof
09/19/2012CN102670641A Liquid composition for contact lens
09/19/2012CN102670564A Preparation method for nimodipine sustained-release pellet capsule
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 531